However, the frequencies of effector CD4+ T cells, regulatory T cells, and B cells increased, suggesting a decrease of proinflammatory cellular immunity in nonpregnant type 2 diabetic patients treated with insulin, as compared to control subjects [33]. Here, CD4 is linked to type 2 diabetes mellitus.